Developer docs
API playgroundTry for free, no card

Search company profiles

Schwabe Pharma Belgium

Full company profile

uuid0059v6c

Namestring
Schwabe Pharma Belgium
Legal namestring
Schwabe Pharma Belgium B.V.
Websiteurl
schwabe.be
Company typeenum
Private
Founded yearint
1985
Descriptiontext

Schwabe Pharma Belgium B.V. is the Belgian commercial subsidiary of the German family-owned Schwabe Group, which was founded in 1866 by Dr. Willmar Schwabe in Leipzig and is now in its fifth generation under Olaf Schwabe. The Belgian entity was established in 1985 (originally as VSM Belgium) and rebranded to its current name in 2018; it operates from Kontich with approximately 25 employees, representing a small fraction of the parent group's roughly 3,500 staff and ~€900 million revenue base.

The company distributes a portfolio of phytopharmaceutical medicines (both prescription and OTC), homeopathic products, and medical devices through Belgian pharmacies. Its offerings target indications commonly addressed by plant-based therapies, with healthcare-professional engagement supported by a dedicated portal (hcp.schwabe.be) protected by DocCheck authentication. The product surface extends into digital health through Tavo, a therapeutic app designed for patients experiencing vertigo, indicating an intent to pair traditional phytotherapy with adjunctive digital tools.

The business model is a B2B2C pharmaceutical distribution model: revenue is generated through wholesale and pharmacy-channel sales of licensed medicines and devices, supplemented by consumer-facing digital content (Tavo). Brand positioning leans on the parent group's botanical and natural-product heritage, reinforced through partnerships with Belgian nature-conservation organizations Natagora and Natuurpunt. No funding rounds, M&A, IPO, or leadership changes specific to the Belgian subsidiary are disclosed in the available data.

Short descriptiontext

Schwabe Pharma Belgium is the Belgian subsidiary of the German family-owned Schwabe Group, distributing phytopharmaceutical medicines, homeopathic products, and medical devices through Belgian pharmacies, with the Tavo vertigo app extending into digital therapeutics.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKontich, Belgium
HQ citystring
Kontich
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
plant-based pharmaceuticals, phytotherapy medicines, homeopathic products, OTC medical devices, digital therapeutics
Industry3 codes
1Sleep, Stress & Mood Support
CodeHLAIADAGPrimaryYes
2Healthy Aging & Cognitive Support Supplements
CodeCRADAGAMPrimaryNo
3Connected Therapeutics & Smart Drug Delivery Monitoring
CodeHLACAFALPrimaryNo
NAICS code2 codes
  • Pharmaceutical Preparation Manufacturing325412
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Ophthalmic Goods3851
Product category
Plant-based Pharmaceuticals (Phytopharmaceuticals)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Prescription Plant-based Medicines
TypeOthers
Description

Prescription-only plant-based medications including Tavoforce, Hyperiplant, and Tavonin tablets. These are dispensed through pharmacies with physician prescription.

schwabe.be
2OTC Plant-based Medicines
TypeOne Time License
Description

Over-the-counter plant-based products available without prescription including Focuzine, Laseaxan, Rodizen, CalmiplantSleep, Dormiplant, Kaloban, and Carmenthin.

schwabe.be
3Homeopathic Products
TypeOne Time License
Description

Homeopathic product line for newborns including mama natura coli, mama natura dento, mama natura gastro, mama natura dormi, mama natura coldprev, Tussioban syrup, and Flexiflor gel.

schwabe.be
4Medical Devices
TypeOne Time License
Description

Medical devices available OTC including Refluthin chewable tablets and Optilan eye drops (bottles and unit doses).

schwabe.be
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales
Pricing details1 tier
1Standard pharmaceutical pricing through pharmacy channels
ModelOtherBilling cadenceMonthly
Notes

Payment terms: 30 days from invoice date via bank transfer to BE53 6451 1229 8753. Late payment interest per Belgian law on payment arrears of August 2, 2002.

schwabe.be
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Tavo App
Description

The first app for smartphones and tablets in Belgium for supporting therapy of benign paroxysmal positional vertigo (BPPV), acute vestibular syndrome, or chronic vertigo. Contains 23 exercises with training videos, written explanations, and auditory support.

schwabe.be
Core offering1 text field

Schwabe Pharma Belgium manufactures and distributes prescription and over-the-counter plant-based (phytopharmaceutical) medicines, homeopathic products, and OTC medical devices through Belgian pharmacy channels, and operates the Tavo digital therapeutic app for vertigo therapy. The Belgian subsidiary is part of the Schwabe Group, which has 160 years of phytotherapy expertise and vertically integrates from plant seed to finished pharmaceutical product to ensure quality, efficacy, and safety in plant-based medicine.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • First app in Belgium for vertigo therapy with 23 evidence-based exercises
+1 more record
Product overview1 text field

Schwabe Pharma Belgium operates as a diversified pharmaceutical company offering three main product categories: (1) Prescription phytopharmaceutical medicines including Tavoforce®, Hyperiplant®, and Tavonin® tablets; (2) Over-the-counter phytopharmaceuticals including Focuzine® 120, Laseaxan®, Rodizen®, CalmiplantSleep®, Dormiplant®, Kaloban® (syrup/drops/tablets), and Carmenthin® soft capsules; (3) Over-the-counter homeopathic range for newborns under the mama natura® brand (coli, dento, gastro, dormi, coldprev drops/tablets) plus Tussioban® syrup and Flexiflor® gel; (4) Over-the-counter medical devices including Refluthin® chewable tablets and Optilan® eye drops; and (5) Tavo app, the company's first digital health application for vertigo therapy. The company positions itself as the Belgian subsidiary of the Schwabe Group, a worldwide leader in plant-based medicine research, development, and production.

Product and service20 records
1Tavoforce
CategoryPrescription phytopharmaceutical medicine
Description

Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.

2Hyperiplant
CategoryPrescription phytopharmaceutical medicine
Description

Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.

3Tavonin
CategoryPrescription phytopharmaceutical medicine
Description

Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.

4Focuzine 120
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter plant-based tablet medication for self-medication, available through Belgian pharmacy channels without a prescription.

5Laseaxan
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter soft capsule plant-based medication for self-medication, available through Belgian pharmacy channels without a prescription.

6Rodizen
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter plant-based tablet medication for self-medication, available through Belgian pharmacy channels without a prescription.

7CalmiplantSleep
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter plant-based tablet medication for sleep support and self-medication, available through Belgian pharmacy channels without a prescription.

8Dormiplant
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter plant-based tablet medication for sleep support and self-medication, available through Belgian pharmacy channels without a prescription.

9Kaloban
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter plant-based medication available in syrup, drops, and tablet forms for self-medication, distributed through Belgian pharmacy channels.

10Carmenthin
CategoryOTC phytopharmaceutical medicine
Description

Over-the-counter soft capsule plant-based medication for self-medication, available through Belgian pharmacy channels without a prescription.

11mama natura coli
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic drops for infants, specifically formulated for colic symptoms, distributed through Belgian pharmacy channels.

12mama natura dento
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic drops for infants, specifically formulated for dental discomfort, distributed through Belgian pharmacy channels.

13mama natura gastro
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic tablets for infants, specifically formulated for digestive issues, distributed through Belgian pharmacy channels.

14mama natura dormi
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic tablets for infants, specifically formulated for sleep support, distributed through Belgian pharmacy channels.

15mama natura coldprev
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic tablets for infants, specifically formulated for common cold prevention or symptoms, distributed through Belgian pharmacy channels.

16Tussioban syrup
CategoryOTC homeopathic medicine
Description

Over-the-counter homeopathic syrup for cough relief, distributed through Belgian pharmacy channels.

17Flexiflor gel
CategoryOTC topical product
Description

Over-the-counter topical gel product, distributed through Belgian pharmacy channels.

18Refluthin chewable tablets
CategoryOTC medical device
Description

Over-the-counter chewable tablets classified as a medical device, distributed through Belgian pharmacy channels.

19Optilan eye drops
CategoryOTC medical device
Description

Over-the-counter eye drops available in both bottle and monodose formats, classified as a medical device, distributed through Belgian pharmacy channels.

20Tavo app
CategoryDigital health application
Description

First smartphone and tablet application in Belgium for supporting therapy of benign paroxysmal positional vertigo (BPPV), acute vestibular syndrome, or chronic dizziness; contains 23 evidence-based exercises with training videos, written explanations, auditory support, reminder functions, and PDF export for patient-physician progress tracking; distributed free in Belgium.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMinorTypeOthers
Description

Nature conservation organization in Wallonia and Brussels. Schwabe supports Natagora financially, including participation in 2022 in purchasing the new Lahage nature reserve (50 hectares) and in 2024 supporting the Parc national de l'Entre-Sambre-et-Meuse project.

Strategic tierMinorTypeOthers
Description

Flemish nature conservation organization. Schwabe provides financial support for nature area acquisition and restoration, particularly at Aronst Hoek nature reserve in Geetbets where curlew protection and habitat monitoring projects are underway.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
1Florsheim (Salus Group)
TypeDirect peer
Description

German family-owned herbal medicinal and tea company distributing plant-based pharmaceutical products through European pharmacy and health-food channels. Closely comparable vertically integrated, family-owned, plant-based pharma business model.

TypeDirect peer
Description

German parent entity producing the phytopharmaceutical products that Schwabe Pharma Belgium distributes. As the upstream manufacturer and innovation source, it is the most directly comparable peer from a product and capability standpoint.

TypeDirect peer
Description

French world leader in homeopathic medicines, distributing OTC homeopathic specialties through European pharmacies. Directly comparable business model for the homeopathic portion of Schwabe's portfolio (mama natura, Tussioban).

TypeBroad incumbent
Description

Global consumer health division of Bayer with extensive OTC herbal lines (e.g., Aspirin Complex, Iberogast). Competes with Schwabe in the broader plant-based OTC category while leveraging far larger scale and global marketing infrastructure.

TypeRegional player
Description

Belgian-headquartered OTC consumer health company (now part of Perrigo) with deep pharmacy distribution across Belgium and a broad herbal/vitamin/supplement portfolio including Davitamon and XLS. Directly competes for the same Belgian pharmacy shelf space and pharmacist recommendation.

TypeDirect peer
Description

German family-owned phytopharmaceutical company that researches, develops, and markets plant-based prescription and OTC medicines. Closest direct competitor to Schwabe in European herbal medicinal products with comparable scientific positioning and pharmacy-channel distribution.

TypeDirect peer
Description

Italian company specializing in plant-based medicinal products and food supplements with vertically integrated cultivation and extraction. Comparable natural-pharma positioning with a similar focus on phytotherapy as a credible alternative to synthetic drugs.

TypeRegional player
Description

German mid-sized pharmaceutical company with a portfolio spanning prescription, OTC, and complementary medicines, including plant-based products. Comparable in size and category overlap, though primarily operating in German-speaking markets rather than Belgium.

TypeBroad incumbent
Description

Major pharmaceutical company with a sizeable consumer health/OTC portfolio including herbal and natural products. Competes in Belgian pharmacy channels and brings substantially broader R&D and marketing resources.

TypeDirect peer
Description

German pharmaceutical company specializing in plant-based and combination homeopathic medicines, distributing globally through pharmacy channels. Comparable phytopharmaceutical/natural medicine business model with similar regulatory positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Schwabe Pharma Belgium

Plant-based Pharmaceuticals (Phytopharmaceuticals)schwabe.be

Schwabe Pharma Belgium is the Belgian subsidiary of the German family-owned Schwabe Group, distributing phytopharmaceutical medicines, homeopathic products, and medical devices through Belgian pharmacies, with the Tavo vertigo app extending into digital therapeutics.

What Schwabe Pharma Belgium does

Schwabe Pharma Belgium B.V. is the Belgian commercial subsidiary of the German family-owned Schwabe Group, which was founded in 1866 by Dr. Willmar Schwabe in Leipzig and is now in its fifth generation under Olaf Schwabe. The Belgian entity was established in 1985 (originally as VSM Belgium) and rebranded to its current name in 2018; it operates from Kontich with approximately 25 employees, representing a small fraction of the parent group's roughly 3,500 staff and ~€900 million revenue base.

The company distributes a portfolio of phytopharmaceutical medicines (both prescription and OTC), homeopathic products, and medical devices through Belgian pharmacies. Its offerings target indications commonly addressed by plant-based therapies, with healthcare-professional engagement supported by a dedicated portal (hcp.schwabe.be) protected by DocCheck authentication. The product surface extends into digital health through Tavo, a therapeutic app designed for patients experiencing vertigo, indicating an intent to pair traditional phytotherapy with adjunctive digital tools.

The business model is a B2B2C pharmaceutical distribution model: revenue is generated through wholesale and pharmacy-channel sales of licensed medicines and devices, supplemented by consumer-facing digital content (Tavo). Brand positioning leans on the parent group's botanical and natural-product heritage, reinforced through partnerships with Belgian nature-conservation organizations Natagora and Natuurpunt. No funding rounds, M&A, IPO, or leadership changes specific to the Belgian subsidiary are disclosed in the available data.

Schwabe Pharma Belgium firmographics

Firmographics
Name
Schwabe Pharma Belgium
Legal name
Schwabe Pharma Belgium B.V.
Website
https://schwabe.be
Company type
Private
Founded year
1985
Operating status
Operating
Headcount range
11–50 employees
Short description
Schwabe Pharma Belgium is the Belgian subsidiary of the German family-owned Schwabe Group, distributing phytopharmaceutical medicines, homeopathic products, and medical devices through Belgian pharmacies, with the Tavo vertigo app extending into digital therapeutics.
Ownership category
akta.pro rank

Schwabe Pharma Belgium industry classification

Industry
Product category
Plant-based Pharmaceuticals (Phytopharmaceuticals)
NAICS
Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834), Ophthalmic Goods (3851)
akta.pro primary industry
Sleep, Stress & Mood Support (HLAIADAG)
akta.pro secondary industries
Healthy Aging & Cognitive Support Supplements (CRADAGAM), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

Keywords

  • Plant-based pharmaceuticals
  • Phytotherapy medicines
  • Homeopathic products
  • OTC medical devices
  • Digital therapeutics

Where Schwabe Pharma Belgium is headquartered

Location

Headquarters

HQ city
Kontich
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Schwabe Pharma Belgium business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Prescription Plant-based Medicines: Prescription-only plant-based medications including Tavoforce, Hyperiplant, and Tavonin tablets. These are dispensed through pharmacies with physician prescription.
  2. OTC Plant-based Medicines: Over-the-counter plant-based products available without prescription including Focuzine, Laseaxan, Rodizen, CalmiplantSleep, Dormiplant, Kaloban, and Carmenthin.
  3. Homeopathic Products: Homeopathic product line for newborns including mama natura coli, mama natura dento, mama natura gastro, mama natura dormi, mama natura coldprev, Tussioban syrup, and Flexiflor gel.
  4. Medical Devices: Medical devices available OTC including Refluthin chewable tablets and Optilan eye drops (bottles and unit doses).

Pricing tiers

ModelBillingPrice
OtherMonthlyStandard pharmaceutical pricing through pharmacy channels

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Schwabe Pharma Belgium product offering

Product offering

Core offering

Schwabe Pharma Belgium manufactures and distributes prescription and over-the-counter plant-based (phytopharmaceutical) medicines, homeopathic products, and OTC medical devices through Belgian pharmacy channels, and operates the Tavo digital therapeutic app for vertigo therapy. The Belgian subsidiary is part of the Schwabe Group, which has 160 years of phytotherapy expertise and vertically integrates from plant seed to finished pharmaceutical product to ensure quality, efficacy, and safety in plant-based medicine.

Product overview

Schwabe Pharma Belgium operates as a diversified pharmaceutical company offering three main product categories: (1) Prescription phytopharmaceutical medicines including Tavoforce®, Hyperiplant®, and Tavonin® tablets; (2) Over-the-counter phytopharmaceuticals including Focuzine® 120, Laseaxan®, Rodizen®, CalmiplantSleep®, Dormiplant®, Kaloban® (syrup/drops/tablets), and Carmenthin® soft capsules; (3) Over-the-counter homeopathic range for newborns under the mama natura® brand (coli, dento, gastro, dormi, coldprev drops/tablets) plus Tussioban® syrup and Flexiflor® gel; (4) Over-the-counter medical devices including Refluthin® chewable tablets and Optilan® eye drops; and (5) Tavo app, the company's first digital health application for vertigo therapy. The company positions itself as the Belgian subsidiary of the Schwabe Group, a worldwide leader in plant-based medicine research, development, and production.

Differentiator

Problem solved

Functional benefit

Brands

  • Tavo App: The first app for smartphones and tablets in Belgium for supporting therapy of benign paroxysmal positional vertigo (BPPV), acute vestibular syndrome, or chronic vertigo. Contains 23 exercises with training videos, written explanations, and auditory support.

Products and services

  • Tavoforce Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.
  • Hyperiplant Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.
  • Tavonin Plant-based pharmaceutical tablet medication available by prescription for the treatment of specified conditions, dispensed through Belgian pharmacies.
  • Focuzine 120 Over-the-counter plant-based tablet medication for self-medication, available through Belgian pharmacy channels without a prescription.
  • Laseaxan Over-the-counter soft capsule plant-based medication for self-medication, available through Belgian pharmacy channels without a prescription.
  • Rodizen Over-the-counter plant-based tablet medication for self-medication, available through Belgian pharmacy channels without a prescription.
  • CalmiplantSleep Over-the-counter plant-based tablet medication for sleep support and self-medication, available through Belgian pharmacy channels without a prescription.
  • Dormiplant Over-the-counter plant-based tablet medication for sleep support and self-medication, available through Belgian pharmacy channels without a prescription.
  • Kaloban Over-the-counter plant-based medication available in syrup, drops, and tablet forms for self-medication, distributed through Belgian pharmacy channels.
  • Carmenthin Over-the-counter soft capsule plant-based medication for self-medication, available through Belgian pharmacy channels without a prescription.
  • mama natura coli Over-the-counter homeopathic drops for infants, specifically formulated for colic symptoms, distributed through Belgian pharmacy channels.
  • mama natura dento Over-the-counter homeopathic drops for infants, specifically formulated for dental discomfort, distributed through Belgian pharmacy channels.
  • mama natura gastro Over-the-counter homeopathic tablets for infants, specifically formulated for digestive issues, distributed through Belgian pharmacy channels.
  • mama natura dormi Over-the-counter homeopathic tablets for infants, specifically formulated for sleep support, distributed through Belgian pharmacy channels.
  • mama natura coldprev Over-the-counter homeopathic tablets for infants, specifically formulated for common cold prevention or symptoms, distributed through Belgian pharmacy channels.
  • Tussioban syrup Over-the-counter homeopathic syrup for cough relief, distributed through Belgian pharmacy channels.
  • Flexiflor gel Over-the-counter topical gel product, distributed through Belgian pharmacy channels.
  • Refluthin chewable tablets Over-the-counter chewable tablets classified as a medical device, distributed through Belgian pharmacy channels.
  • Optilan eye drops Over-the-counter eye drops available in both bottle and monodose formats, classified as a medical device, distributed through Belgian pharmacy channels.
  • Tavo app First smartphone and tablet application in Belgium for supporting therapy of benign paroxysmal positional vertigo (BPPV), acute vestibular syndrome, or chronic dizziness; contains 23 evidence-based exercises with training videos, written explanations, auditory support, reminder functions, and PDF export for patient-physician progress tracking; distributed free in Belgium.

Quantifiable outcome

  • First app in Belgium for vertigo therapy with 23 evidence-based exercises
  • +1 more outcomes

Companies that use Schwabe Pharma Belgium

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles3 records

Schwabe Pharma Belgium technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Schwabe Pharma Belgium partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered minor.

  • NatagoraminorOthersNature conservation organization in Wallonia and Brussels. Schwabe supports Natagora financially, including participation in 2022 in purchasing the new Lahage nature reserve (50 hectares) and in 2024 supporting the Parc national de l'Entre-Sambre-et-Meuse project.
  • NatuurpuntminorOthersFlemish nature conservation organization. Schwabe provides financial support for nature area acquisition and restoration, particularly at Aronst Hoek nature reserve in Geetbets where curlew protection and habitat monitoring projects are underway.

Scale indicators6 records

Recent moves4 records

Expansion highlights3 records

Schwabe Pharma Belgium competitors and assessment

Company assessment

Direct peers

  • Florsheim (Salus Group): German family-owned herbal medicinal and tea company distributing plant-based pharmaceutical products through European pharmacy and health-food channels. Closely comparable vertically integrated, family-owned, plant-based pharma business model.
  • Schwabe Group (parent): German parent entity producing the phytopharmaceutical products that Schwabe Pharma Belgium distributes. As the upstream manufacturer and innovation source, it is the most directly comparable peer from a product and capability standpoint.
  • Boiron: French world leader in homeopathic medicines, distributing OTC homeopathic specialties through European pharmacies. Directly comparable business model for the homeopathic portion of Schwabe's portfolio (mama natura, Tussioban).
  • Bionorica: German family-owned phytopharmaceutical company that researches, develops, and markets plant-based prescription and OTC medicines. Closest direct competitor to Schwabe in European herbal medicinal products with comparable scientific positioning and pharmacy-channel distribution.
  • Aboca: Italian company specializing in plant-based medicinal products and food supplements with vertically integrated cultivation and extraction. Comparable natural-pharma positioning with a similar focus on phytotherapy as a credible alternative to synthetic drugs.
  • Heel (Biologische Heilmittel Heel): German pharmaceutical company specializing in plant-based and combination homeopathic medicines, distributing globally through pharmacy channels. Comparable phytopharmaceutical/natural medicine business model with similar regulatory positioning.

Broad incumbents

  • Bayer Consumer Health: Global consumer health division of Bayer with extensive OTC herbal lines (e.g., Aspirin Complex, Iberogast). Competes with Schwabe in the broader plant-based OTC category while leveraging far larger scale and global marketing infrastructure.
  • Sanofi Consumer Healthcare: Major pharmaceutical company with a sizeable consumer health/OTC portfolio including herbal and natural products. Competes in Belgian pharmacy channels and brings substantially broader R&D and marketing resources.

Regional players

  • Omega Pharma (Perrigo): Belgian-headquartered OTC consumer health company (now part of Perrigo) with deep pharmacy distribution across Belgium and a broad herbal/vitamin/supplement portfolio including Davitamon and XLS. Directly competes for the same Belgian pharmacy shelf space and pharmacist recommendation.
  • Wörwag Pharma: German mid-sized pharmaceutical company with a portfolio spanning prescription, OTC, and complementary medicines, including plant-based products. Comparable in size and category overlap, though primarily operating in German-speaking markets rather than Belgium.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Schwabe Pharma Belgium social profiles

Digital presence

Schwabe Pharma Belgium financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Schwabe Pharma Belgium leadership team

Management profile

Number of profiles

Profiles1 record

Schwabe Pharma Belgium funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Schwabe Pharma Belgium M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Schwabe Pharma Belgium

What does Schwabe Pharma Belgium do?

Schwabe Pharma Belgium manufactures and distributes prescription and over-the-counter plant-based (phytopharmaceutical) medicines, homeopathic products, and OTC medical devices through Belgian pharmacy channels, and operates the Tavo digital therapeutic app for vertigo therapy. The Belgian subsidiary is part of the Schwabe Group, which has 160 years of phytotherapy expertise and vertically integrates from plant seed to finished pharmaceutical product to ensure quality, efficacy, and safety in plant-based medicine.

Is Schwabe Pharma Belgium a public or private company?

Schwabe Pharma Belgium is a private company. It is classified as family owned and is currently operating.

When was Schwabe Pharma Belgium founded?

Schwabe Pharma Belgium was founded in 1985. It employs 11 to 50 people.

Where is Schwabe Pharma Belgium based?

Schwabe Pharma Belgium is headquartered in Kontich, Belgium, in the Europe region.

How does Schwabe Pharma Belgium make money?

Four revenue lines are on record. Prescription Plant-based Medicines are the primary driver. The others are OTC Plant-based Medicines, homeopathic Products and medical Devices.

Who are Schwabe Pharma Belgium's main competitors?

Direct peers on record are Florsheim (Salus Group), Schwabe Group (parent), Boiron, Bionorica, Aboca and Heel (Biologische Heilmittel Heel). Broad incumbents are Bayer Consumer Health and Sanofi Consumer Healthcare. Regional players are Omega Pharma (Perrigo) and Wörwag Pharma.

Does Schwabe Pharma Belgium have an API?

No public API is recorded for Schwabe Pharma Belgium.

What industry is Schwabe Pharma Belgium in?

Schwabe Pharma Belgium's product category is Plant-based Pharmaceuticals (Phytopharmaceuticals). Its primary akta.pro industry code is HLAIADAG, Sleep, Stress & Mood Support, with a secondary code of CRADAGAM, Healthy Aging & Cognitive Support Supplements. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales